Thursday, December 16, 2021

It's official! The Panoramic trial is all go!



Recently we announced our involvement in another incredibly exciting trial, aimed at finding effective treatments for people in the community which will prevent people from being hospitalised with Covid-19.

This trial was awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

Known as PANORAMIC, this trial is led by Oxford University’s Primary Care Clinical Trials Unit, while the delivery of the trial will be supported by the NIHR Clinical Research Network and devolved administrations.

In a new development, we’re thrilled to report that the UK government has announced that thousands of the UK’s most vulnerable people will be among the first in the world to access these life-saving, cutting-edge antiviral and antibody treatments from December.

“This opens up a new era for the treatment of COVID-19, one where we can begin to cover every phase of contracting this deadly disease – whether it be before you catch it, just after you catch it, if you develop symptoms or if you require hospital care.” - UK Health and Social Care Secretary Sajid Javid

The study will be trialling the use of Molnupiravir, an anti-viral drug shown in clinical trials to reduce the risk of hospitalisation or death for at-risk, non-hospitalised adults with mild to moderate COVID-19 by 30%.

Taking part in the study will require participants to complete a daily diary for 28 days through the PANORAMIC website or receive a phone call from the trial team on days 7, 14 and 28 to speak about their symptoms. The first set of results from the trial is anticipated in early 2022.

Spiral will be supporting with our savvy software platform and our ability to pivot with change. Unlike others, we can adapt our platform for Novel Trials or studies that use unusual design methodologies. We’re excited to keep you informed about this groundbreaking trial - one that we feel privileged to be a part of.

Keep up to date with the Panoramic trial via our Trial Hub page here. We will be refreshing it with new information as and when it is made available.

Dive Deeper:

Press Release - UK’S Most Vulnerable People to receive life-saving Covid-19 treatments in the community